Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01819194 · ClinicalTrials.gov registry record · NA

Contact Lens Comfort Relative to Meibomian Gland Status

A NA study, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
64
Enrollment target

NCT01819194 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 64 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01819194, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
64 participants
Enrollment target

Study Summary

This trial aims to establish a correlation between patient reported comfort while using soft contact lenses and meibomian gland dysfunction (MGD).

Interventions

  • DEVICE senofilcon A

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2013-03
Est. Completion 2013-08
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT01819194

The ClinicalTrials.gov registry entry for NCT01819194 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which senofilcon A is the first listed.

NCT01819194 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01819194 about?

NCT01819194 is a clinical study titled "Contact Lens Comfort Relative to Meibomian Gland Status". This trial aims to establish a correlation between patient reported comfort while using soft contact lenses and meibomian gland dysfunction (MGD).

What is the current status of trial NCT01819194?

This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2013-03. Estimated completion is 2013-08.

What interventions are being tested in trial NCT01819194?

The interventions under investigation include: senofilcon A (DEVICE).

Who is sponsoring clinical trial NCT01819194?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.